Bell is committed to continued support for post-secondary student mental health and wellness across Canada. Bell Let’s Talk funding enabled the creation of the National Standard of Canada for Mental Health and Well-Being for Post-Secondary Students (the Standard), under the leadership of the Mental Health Commission of Canada (MHCC) and in partnership with the Canadian Standards Association (CSA).

Bell is building on this commitment to support student success with the creation of the Bell Let’s Talk Post-Secondary Fund. The Post-Secondary Fund will include two initiatives to support post-secondary institutions in their journey to implement the Standard. The first funding initiative to be made available is the Bell Let’s Talk Post-Secondary Fund Kickoff Grant.

In 2021, 100 Kickoff Grants are available to eligible Canadian publicly funded post-secondary institutions. The one-time $25,000 Kickoff Grant supports research and other activities that institutions undertake to begin their journey to align with the Standard. The period for submitting an application for a Kickoff Grant is open to February 26.

As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).

Subject to the FY21 Congressional appropriation for LCRP funding, FY21 LCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.    

Applications submitted to the FY21 LCRP must address one or more of the following Areas of Emphasis:

• Identify innovative strategies for prevention of the occurrence of lung cancer.
• Identify innovative strategies for the screening and early detection of lung cancer.
• Understand the molecular mechanisms of initiation and progression to lung cancer.
• Understand contributors to lung cancer development other than tobacco.
• Identify innovative strategies for the treatment of lung cancer.
• Identify innovative strategies for the prevention of recurrence of or metastases from lung cancer.
• Develop or optimize prognostic or predictive markers to assist with therapeutic decision-making.
• Understand mechanisms of resistance to treatment (primary and secondary).
• Identify innovative strategies for lung cancer care delivery (clinical management/surveillance/symptom management).
• Understand factors that contribute to the health disparities in lung cancer, such as biological contributors; environmental, social, and cultural factors; and access to health care.

https://cdmrp.army.mil/funding/lcrp

Concept Award – Letter of Intent Due April 6, 2021

All investigators at or above the level of postdoctoral fellow (or equivalent)

• Supports highly innovative, untested, potentially groundbreaking concepts in lung cancer.
• Emphasis on innovative concept or untested theory.
• Research involving human subjects or specimens must be either exempt under Title 32, Code of Federal Regulations (CFR), Part 219, Section 104(d)(32 CFR 219.104[d]) or eligible for expedited review (21 CFR 56.110).
• Clinical trials not allowed.
• Preliminary data discouraged (not consistent with intent of award mechanism).
• Military relevance strongly encouraged.
• Maximum funding of $100,000 in direct costs (plus indirect costs).
• Period of performance should not exceed 1 year.

Career Development Award – Letter of Intent Due April 6, 2021

• Principal Investigator:  Independent investigators at the level of Assistant Professor, Instructor, or equivalent; must be within 5 years of first faculty appointment (or equivalent)
• Most not have received a Career Development Award previously from any program within the Congressionally Directed Medical Research Programs.
• Must not have received more than $300,000 in total direct costs for previous or concurrent lung cancer research as a PI of one or more federally or privately funded, non-mentored, peer-reviewed grants.

Mentor:  At or above the level of Associate Professor (or equivalent),

Must have a strong publication and funding record in lung cancer research

• Supports early-career, independent researchers to conduct research under mentorship of an experienced lung cancer researcher.
• Emphasis on research with high potential impact.
• Clinical trials not allowed.
• Career development plan is required with appropriate mentor guidance.
• Preliminary data not required.
• Military relevance strongly encouraged.
• Maximum funding of $250,000 in direct costs (plus indirect costs).
• Period of performance should not exceed 2 years.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

For more information about the LCRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk

301-682-5507 
help@eBrap.org

The FY21 Defense Appropriations Act is anticipated to provide funding to the Department of Defense OCRP to support patient-centered research to prevent, detect, treat, and cure ovarian cancer to enhance the health and well-being of Service members, Veterans, retirees, their family members, and all women impacted by this disease.  As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).

FY21 OCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.    

https://cdmrp.army.mil/funding/ocrp

Investigator-Initiated Research Award – Pre-application due April 1, 2021

Must be an independent investigator at or above the level of Assistant Professor (or equivalent).

Partnering PI Option:  
Up to two investigators may collaborate on a single application, each of whom will be recognized as a Principal Investigator (PI) and receive a separate award. 

• Supports meritorious basic and clinically oriented research in ovarian cancer.
• Impact is an important review criterion.
• Preliminary data are required.
• Clinical trials are not allowed. 

Pre-application is required; application submission is by invitation only.

• Maximum funding of $600,000 for direct costs (plus indirect costs).
• Maximum funding of $800,000 for direct costs (plus indirect costs) for Partnering PI Option.
• Maximum period of performance is 4 years.

Ovarian Cancer Academy Award – Early-Career Investigator – Pre-application due April 1, 2021

Must be within 5 years of his/her last postdoctoral research position (Ph.D.) or clinical fellowship (M.D.), or equivalent as of the full application submission deadline.

A statement of eligibility is required.

• Supports the addition of new Early-Career Investigators to the unique, interactive virtual academy providing intensive mentoring, national networking, and a peer group for junior faculty.
• Early-Career Investigators whose ability to commit to conducting ovarian cancer research is limited by lack of resources or other overwhelming obstacles are encouraged to apply.
• A Designated Mentor who is an experienced ovarian cancer researcher with ovarian cancer funding is required.
• A Designated Mentor may only mentor one Early-Career Investigator.
• The Designated Mentor is not required to be at the same institution as the Early-Career Investigator.
• Preliminary data are required.
• Clinical trials are allowed.
• Pre-application is required; application submission is by invitation only.
• Maximum funding of $725,000 for direct costs (plus indirect costs).
• Maximum period of performance is 4 years.

Pilot Award – Pre-application is Due April 1, 2021

Investigators at or above the postdoctoral level (or equivalent).

• Supports innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ovarian cancer research forward.
• Innovation and Impact are important review criteria.
• Goal is to develop preliminary data; thus, preliminary data are not required, but are allowed.
• Clinical trials are not allowed.
• Pre-application is required and blinded; application submission is by invitation only.
• Maximum funding of $250,000 for direct costs (plus indirect costs).
• Maximum period of performance is 2 years.

Clinical Translational Research Award - Pre-application Due April 1, 2021

Must be an independent investigator at or above the level of Assistant Professor (or equivalent).

• Supports translational research addressing high-impact or unmet needs in ovarian cancer.
• Supports correlative studies related to or associated with planned, ongoing, or completed clinical trials supported by other funding sources. 
• Emphasis on the utilization of precision medicine and computational approaches that identify individual tumor characteristics and predictive biomarkers across diverse groups to optimize patient care and outcomes.
• Preliminary data are required.
• Clinical trials are not allowed.
• Pre-application is required; application submission is by invitation only.
  • Maximum funding of $450,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.

Proteogenomics Research Award – Pre-application due April 1, 2021

Must be at or above the level of postdoctoral fellow (or equivalent).

• Supports the genomic and/or transcriptomic and/or proteomic analysis of currently available clinical specimens with a focus on answering biologic and pathophysiologic questions of clinical relevance in ovarian cancer.
• Innovation and impact are important review criteria.
• Analysis of clinical trial-derived specimens and/or large patient specimen cohorts is encouraged.
• Clinical trials are not allowed.
• Preliminary data are not required but are allowed.
• Submission of a Letter of Intent is required prior to full application submission.
  • Maximum funding of $250,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

For more information about the OCRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk
301-682-5507 
help@eBrap.org

Description of the funding

Eligible organizations can apply for up to $250,000 per year per project (with a maximum of $750,000 over 3 years). We will fund accessibility standards research projects that focus on one or more of the following priority areas:

• accessibility in Indigenous communities
• built environment with a focus on heritage buildings
• communication, other than plain language
• design and delivery of programs and services
• information and communication technology
• procurement (buying) of goods, services and facilities

Objective

This funding supports projects that:

• advance/ inform research on accessibility standards to help develop new or revise existing accessibility standards that fall under federal areas of responsibilities; 
• connect people with disabilities, other experts, and partners in the disability field and other fields to design and implement the research; and
• share findings of research, information, best practices and tools on accessibility barriers and standards.

The Stratas Foundation is the first volunteer not-for-profit organization dedicated to funding Canadian mental health research by early career researchers. Help us invest in new, innovative ideas by applying for funding below.

Our Selections Committee will determine the winning candidate during the Review Period in March. The winner will be contacted following the Review Period.

The deadline to submit your application form for this $1,000 award is February 28, 2021 at 11:59 PM EST.

NOTE:

Applicants should prepare the following documents ahead of time to complete the application:

- A 1-page research proposal + bibliography
- Confirmation of enrollment or employment at a Canadian university or research institute
- Contact information
- Names of investigators and co-investigators

Hunt Postdoctoral Fellowships (writing) provide up to $40,000 towards the writing-up of already completed research. The fellowship is awarded to early career scholars, who frequently lack the time and resources they need to publish their work. Applicants should be no more than ten years beyond their PhD, with allowances made for periods of caregiving, and have a doctorate in anthropology or an equivalent field. A maximum of eight Hunt Postdoctoral Fellowships are awarded annually.

Post-Ph.D. Research Grants are awarded to individuals holding a Ph.D. or equivalent degree to support individual research projects. The program contributes to the Foundation's overall mission to support basic research in anthropology and to ensure that the discipline continues to be a source of vibrant and significant work that furthers our understanding of humanity's cultural and biological origins, development, and variation. The Foundation supports research that demonstrates a clear link to anthropological theory and debates, and promises to make a solid contribution to advancing these ideas. There is no preference for any methodology, research location, or subfield. The Foundation particularly welcomes proposals that employ a comparative perspective, can generate innovative approaches or ideas, and/or integrate two or more subfields.